Teva Launches Generic Pravachol Following Appeals Court Dismissal Of Apotex

Watson concurrently launched an authorized generic of Bristol's pravastatin, but Ranbaxy's 80 mg ANDA remains on hold.

More from Archive

More from Pink Sheet